OBJECT: A hollow fiber catheter was developed to improve the distribution of drugs administered via direct infusion into the central nervous system (CNS). It is a porous catheter that significantly increases the surface area of brain tissue into which a drug is infused. METHODS: Dye was infused into the mouse brain through convection-enhanced delivery (CED) using a 28-gauge needle compared with a 3-mm-long hollow fiber catheter. To determine whether a hollow fiber catheter could increase the distribution of gene therapy vectors, a recombinant adenovirus expressing the firefly luciferase reporter was injected into the mouse striatum. Gene expression was monitored using in vivo bioluminescent imaging. To assess the distribution of gene transfer, an adenovirus expressing green fluorescent protein was injected into the striatum using a hollow fiber catheter or a needle. RESULTS: Hollow fiber catheter-mediated infusion increased the volume of brain tissue labeled with dye by 2.7 times relative to needle-mediated infusion. In vivo imaging revealed that catheter-mediated infusion of adenovirus resulted in gene expression that was 10-times greater than that mediated by a needle. The catheter appreciably increased the area of brain transduced with adenovirus relative to a needle, affecting a significant portion of the injected hemisphere. CONCLUSIONS: The miniature hollow fiber catheter used in this study significantly increased the distribution of dye and adenoviral-mediated gene transfer in the mouse brain compared with the levels reached using a 28-gauge needle. Compared with standard single-port clinical catheters, the hollow fiber catheter has the advantage of millions of nanoscale pores to increase surface area and bulk flow in the CNS. Extending the scale of the hollow fiber catheter for the large mammalian brain shows promise in increasing the distribution and efficacy of gene therapy and drug therapy using CED.
OBJECT: A hollow fiber catheter was developed to improve the distribution of drugs administered via direct infusion into the central nervous system (CNS). It is a porous catheter that significantly increases the surface area of brain tissue into which a drug is infused. METHODS: Dye was infused into the mouse brain through convection-enhanced delivery (CED) using a 28-gauge needle compared with a 3-mm-long hollow fiber catheter. To determine whether a hollow fiber catheter could increase the distribution of gene therapy vectors, a recombinant adenovirus expressing the firefly luciferase reporter was injected into the mouse striatum. Gene expression was monitored using in vivo bioluminescent imaging. To assess the distribution of gene transfer, an adenovirus expressing green fluorescent protein was injected into the striatum using a hollow fiber catheter or a needle. RESULTS: Hollow fiber catheter-mediated infusion increased the volume of brain tissue labeled with dye by 2.7 times relative to needle-mediated infusion. In vivo imaging revealed that catheter-mediated infusion of adenovirus resulted in gene expression that was 10-times greater than that mediated by a needle. The catheter appreciably increased the area of brain transduced with adenovirus relative to a needle, affecting a significant portion of the injected hemisphere. CONCLUSIONS: The miniature hollow fiber catheter used in this study significantly increased the distribution of dye and adenoviral-mediated gene transfer in the mouse brain compared with the levels reached using a 28-gauge needle. Compared with standard single-port clinical catheters, the hollow fiber catheter has the advantage of millions of nanoscale pores to increase surface area and bulk flow in the CNS. Extending the scale of the hollow fiber catheter for the large mammalian brain shows promise in increasing the distribution and efficacy of gene therapy and drug therapy using CED.
Authors: John R Ohlfest; Zachary L Demorest; Yasuhiko Motooka; Isabelita Vengco; Seunguk Oh; Eleanor Chen; Frank A Scappaticci; Rachel J Saplis; Stephen C Ekker; Walter C Low; Andrew B Freese; David A Largaespada Journal: Mol Ther Date: 2005-09-16 Impact factor: 11.454
Authors: Raghu Raghavan; Martin L Brady; María Inmaculada Rodríguez-Ponce; Andreas Hartlep; Christoph Pedain; John H Sampson Journal: Neurosurg Focus Date: 2006-04-15 Impact factor: 4.047
Authors: Sumia Ali; Gwendalyn D King; James F Curtin; Marianela Candolfi; Weidong Xiong; Chunyan Liu; Mariana Puntel; Queng Cheng; Jesus Prieto; Antoni Ribas; Jerzy Kupiec-Weglinski; Nico van Rooijen; Hans Lassmann; Pedro R Lowenstein; Maria G Castro Journal: Cancer Res Date: 2005-08-15 Impact factor: 12.701
Authors: Christoph Mamot; John B Nguyen; Micheal Pourdehnad; Piotr Hadaczek; Ryuta Saito; John R Bringas; Daryl C Drummond; Keelung Hong; Dmitri B Kirpotin; Tracy McKnight; Mitchel S Berger; John W Park; Krys S Bankiewicz Journal: J Neurooncol Date: 2004-05 Impact factor: 4.130
Authors: Martin L Brady; Raghu Raghavan; Walter Block; Benjamin Grabow; Chris Ross; Ken Kubota; Andrew L Alexander; Marina E Emborg Journal: Stereotact Funct Neurosurg Date: 2015-02-18 Impact factor: 1.875
Authors: B J King; T K Mann-Gow; M Kida; M K Plante; S D Perrapato; P Zvara Journal: Prostate Cancer Prostatic Dis Date: 2015-05-26 Impact factor: 5.554
Authors: Benjamin J King; Mark K Plante; Masatoshi Kida; Travis K Mann-Gow; Rick Odland; Peter Zvara Journal: J Urol Date: 2012-03-16 Impact factor: 7.450
Authors: Seunguk Oh; John R Ohlfest; Deborah A Todhunter; Vincent D Vallera; Walter A Hall; Hua Chen; Daniel A Vallera Journal: J Neurooncol Date: 2009-06-11 Impact factor: 4.130
Authors: Matthew D Stone; Rick M Odland; Thomas McGowan; Getiria Onsongo; Chaunning Tang; Nelson L Rhodus; Pratik Jagtap; Sricharan Bandhakavi; Timothy J Griffin Journal: Clin Proteomics Date: 2010-07-25 Impact factor: 3.988